Industry News — Clinical Updates

First US Patients Receive Commercial Implants of Argus II

Second Sight Medical Products Inc. (Symlar, CA) has announced the first surgical implants of the Argus® II Retinal Prosthesis System in the United States since the system’s 2013 US Food and Drug Administration (FDA) approval.

The systems were implanted in 2 retinitis pigmentosa (RP) patients at the University of Michigan’s Kellogg Eye Center. Ultimate outcomes of the patients’ Argus II implants will not be known until they complete rehabilitation training to use the device.

Kellogg Eye Center has selected additional patients to receive the implant. It is 1 of 12 centers in the United States that accepts Argus II consultations.

 

Updated: January 30, 2014

Designed and built in Chicago by Webitects